1. Home
  2. EUDA vs AYTU Comparison

EUDA vs AYTU Comparison

Compare EUDA & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EUDA Health Holdings Limited

EUDA

EUDA Health Holdings Limited

HOLD

Current Price

$14.10

Market Cap

24.3M

Sector

Finance

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.45

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EUDA
AYTU
Founded
2021
N/A
Country
Singapore
United States
Employees
117
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
27.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
EUDA
AYTU
Price
$14.10
$2.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$55.00
$9.33
AVG Volume (30 Days)
325.3K
29.6K
Earning Date
12-19-2023
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,632,080.00
Revenue This Year
$134.73
N/A
Revenue Next Year
$195.03
$43.75
P/E Ratio
$123.62
N/A
Revenue Growth
N/A
277.47
52 Week Low
$0.33
$1.26
52 Week High
$25.70
$3.07

Technical Indicators

Market Signals
Indicator
EUDA
AYTU
Relative Strength Index (RSI) 62.67 39.46
Support Level $1.87 $2.15
Resistance Level $15.36 $2.64
Average True Range (ATR) 4.44 0.09
MACD 0.02 -0.01
Stochastic Oscillator 42.03 1.96

Price Performance

Historical Comparison
EUDA
AYTU

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia, and China. It offers inventive, accessible, and science-based health solutions to support the shift in regional healthcare from reactive medical treatment to proactive, longevity-focused care. The group also runs a Singapore-based property management business. It operates in two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include management and security services for properties such as condominiums, residential apartments, business office buildings, and shopping malls.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: